|
DK200200474A
|
|
Novel 2,3-di-substd.-1,3-dioxolane(s) - used as antiviral esp. anti-aids agents
|
|
US2003087918A1
|
|
Substituted 1,3-oxathiolanes
|
|
AU3527801A
|
|
Method for the treatment or prevention of flavivirus infections using nucleoside analogues
|
|
WO0158894A1
|
|
Stereoselective synthesis of nucleoside analogues
|
|
WO0149700A1
|
|
Imidazopyrimidine nucleoside analogues with anti-hiv activity
|
|
US6369066B1
|
|
Substituted 1,3-oxathiolanes with antiviral properties
|
|
US6566365B1
|
|
Method for the treatment of Flaviviridea viral infection using nucleoside analogues
|
|
WO0075129A1
|
|
Thiophene integrin inhibitors
|
|
AU3638600A
|
|
Proteinase K resistant surface protein of neisseria meningitidis
|
|
US6444656B1
|
|
Antiviral phosphonate nucleotides
|
|
US6511983B1
|
|
Pharmaceutical combination of antiviral agents
|
|
AU2653200A
|
|
Stereoselective synthesis of nucleoside analogues
|
|
WO0039299A2
|
|
Streptococcus antigens
|
|
AU5991699A
|
|
Quinolizinones as integrin inhibitors
|
|
EP1091952A1
|
|
Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer
|
|
AU3724699A
|
|
Fumagillin analogs and their use as angiogenesis inhibitors
|
|
WO9961432A1
|
|
Fumagillin analogs and their use as angiogenesis inhibitors
|
|
AP200001886A0
|
|
Group b streptococcus antigens
|
|
US6255318B1
|
|
Antiviral compounds
|
|
US6350753B1
|
|
2-Substituted-4-substituted-1,3-dioxolanes and use thereof
|
